Literature DB >> 30175877

An evaluation of veterinary allergen extract content and resultant canine intradermal threshold concentrations.

Stephanie B Abrams1, Guy N Brock2, Marilly Palettas2, Michelle L Bolner3, Tricia Moore-Sowers3, Greg A Plunkett3, Lynette K Cole1, Sandra F Diaz1, Gwendolen Lorch1.   

Abstract

BACKGROUND: Limited information is available for dogs on threshold concentrations (TCs), and the protein composition of common allergenic extracts produced by different manufacturers. HYPOTHESIS/
OBJECTIVES: To characterize the protein heterogeneity of tree, grass, weed and mite allergens from different lots of allergenic extracts, and to determine intradermal TCs for healthy dogs using extracts from two manufacturers. ANIMALS: Twenty five privately owned, clinically healthy dogs and ten purpose-bred beagle dogs. METHODS AND MATERIALS: Protein concentration and heterogeneity of 11 allergens from two manufacturers were evaluated using a Bradford-style assay and SDS-PAGE. Intradermal testing was performed with 11 allergens from each company at four dilutions. Immediate reactions were subjectively scored (0 to 4+), and objectively measured (mm) and their percentage concordance evaluated. Model-based TCs were determined by fitting positive reactions (≥2+) at 15 min to generalized estimating equations.
RESULTS: Allergen extract protein quantity and composition varied within and between manufacturers despite sharing the same PNU/mL values. Model-based TCs of one weed, five trees, two grasses and a house dust mite were determined for extracts from Manufacturer 1 (M1), and for extracts of three weeds, three trees and two grasses from Manufacturer 2 (M2). Receiver operating characteristic curve analyses determined a percentage concordance of the objective and subjective measurements of 77.3% for M1 and 75% for M2 allergens. CONCLUSIONS AND CLINICAL IMPORTANCE: Veterinary allergen extracts labelled as the same species and PNU/mL are not standardized; they show heterogeneity in composition and potency within and between manufacturers. Variability in extract content may require adjustment of intradermal testing concentrations.
© 2018 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30175877      PMCID: PMC9017537          DOI: 10.1111/vde.12686

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.867


  29 in total

Review 1.  Regulatory aspects of allergen vaccines in the US.

Authors:  K S Morrow; J E Slater
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Molecular Allergen-Specific IgE Assays as a Complement to Allergen Extract-Based Sensitization Assessment.

Authors:  Rob C Aalberse; Joost A Aalberse
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Nov-Dec

3.  The novel high molecular weight Dermatophagoides farinae protein Zen-1 is a major allergen in North American and European mite allergic dogs with atopic dermatitis.

Authors:  Thierry Olivry; Stanley M Dunston; Claude Favrot; Pascal Prélaud; Toshiroh Tsukui
Journal:  Vet Dermatol       Date:  2016-11-07       Impact factor: 1.589

4.  Intradermal and serological testing for mites in healthy beagle dogs.

Authors:  Stefanie Koebrich; Claudia Nett-Mettler; Sylvia Wilhelm; Claude Favrot
Journal:  Vet Dermatol       Date:  2012-03-20       Impact factor: 1.589

5.  Comparison of subjective and objective intradermal allergy test scoring methods in dogs with atopic dermatitis.

Authors:  Tomeshia L Hubbard; Patricia D White
Journal:  J Am Anim Hosp Assoc       Date:  2011 Nov-Dec       Impact factor: 1.023

Review 6.  Mass spectrometry to complement standardization of house dust mite and other complex allergenic extracts.

Authors:  J Spiric; A Reuter; R L Rabin
Journal:  Clin Exp Allergy       Date:  2017-05       Impact factor: 5.018

7.  Immunoproteomic characterization of a Dermatophagoides farinae extract used in the treatment of canine atopic dermatitis.

Authors:  Raquel Moya; Jerónimo Carnés; Nuria Sinovas; Laura Ramió; Pilar Brazis; Anna Puigdemont
Journal:  Vet Immunol Immunopathol       Date:  2016-08-04       Impact factor: 2.046

8.  Identification, characterization, and cloning of a complementary DNA encoding a 60-kd house dust mite allergen (Der f 18) for human beings and dogs.

Authors:  Eric Weber; Shirley Hunter; Kim Stedman; Steve Dreitz; Thierry Olivry; Andrew Hillier; Catherine McCall
Journal:  J Allergy Clin Immunol       Date:  2003-07       Impact factor: 10.793

9.  Comparison of the intradermal irritant threshold concentrations of nine allergens from two different manufacturers in clinically nonallergic dogs in the USA.

Authors:  Desirae A Foust-Wheatcraft; Darin L Dell; Wayne S Rosenkrantz; Craig E Griffin
Journal:  Vet Dermatol       Date:  2017-06-29       Impact factor: 1.589

Review 10.  Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project.

Authors:  A Bonertz; G Roberts; J E Slater; J Bridgewater; R L Rabin; M Hoefnagel; M Timon; C Pini; O Pfaar; A Sheikh; D Ryan; C Akdis; J Goldstein; L K Poulsen; R van Ree; C Rhyner; D Barber; O Palomares; R Pawankar; D Hamerlijnk; L Klimek; I Agache; E Angier; T Casale; M Fernandez-Rivas; S Halken; M Jutel; S Lau; G Pajno; G Sturm; E M Varga; R Gerth van Wijk; S Bonini; A Muraro; S Vieths
Journal:  Allergy       Date:  2018-01-10       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.